Macitentan - Johnson & Johnson Innovative Medicine
At a glance
- Drug Originator Actelion Pharmaceuticals
- Drug Licenced by Knight Therapeutics; Nippon Shinyaku
- Drug Class Antifibrotics; Antihypertensives; Antineoplastics; Bromobenzenes; Cardiovascular therapies; Heart failure therapies; Pyrimidines; Skin disorder therapies; Small molecules; Sulfonamides
- Mechanism of Action Endothelin A receptor antagonists; Endothelin B receptor antagonists
- USA Patent Applicants ACTELION
- USA Patents 8
- NDAs 1
- International Patents 94
- Patent Applications 451
Table of Contents
Disclaimer